|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
23
|
|
pubmed:dateCreated |
2008-12-2
|
|
pubmed:abstractText |
This phase I infusion rate escalation trial was undertaken to evaluate the maximum applicable infusion rate for rituximab without steroid premedication in patients having received one previous rituximab infusion.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Dec
|
|
pubmed:issn |
1078-0432
|
|
pubmed:author |
pubmed-author:GallinoAugustoA,
pubmed-author:GhielminiMicheleM,
pubmed-author:LeonciniLedaL,
pubmed-author:LerchErikaE,
pubmed-author:MoraOresteO,
pubmed-author:NegrettiLauraL,
pubmed-author:ObersonMichelM,
pubmed-author:Rodriguez-AbreuDelvysD,
pubmed-author:SessaCristianaC,
pubmed-author:SianoMarcoM,
pubmed-author:ZuccaEmanueleE
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
1
|
|
pubmed:volume |
14
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
7935-9
|
|
pubmed:dateRevised |
2010-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:19047125-Adult,
pubmed-meshheading:19047125-Aged,
pubmed-meshheading:19047125-Antibodies, Monoclonal,
pubmed-meshheading:19047125-Antibodies, Monoclonal, Murine-Derived,
pubmed-meshheading:19047125-Antineoplastic Agents,
pubmed-meshheading:19047125-Blood Pressure,
pubmed-meshheading:19047125-Electrocardiography,
pubmed-meshheading:19047125-Female,
pubmed-meshheading:19047125-Heart,
pubmed-meshheading:19047125-Humans,
pubmed-meshheading:19047125-Lymphoma, B-Cell,
pubmed-meshheading:19047125-Male,
pubmed-meshheading:19047125-Maximum Tolerated Dose,
pubmed-meshheading:19047125-Middle Aged,
pubmed-meshheading:19047125-Natriuretic Peptide, Brain,
pubmed-meshheading:19047125-Troponin
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
A phase I-II study to determine the maximum tolerated infusion rate of rituximab with special emphasis on monitoring the effect of rituximab on cardiac function.
|
|
pubmed:affiliation |
Department of Medical Oncology and Cardiology, Ospedale San Giovanni, Bellinzona, Switzerland.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Clinical Trial, Phase II,
Clinical Trial, Phase I
|
